Role of Hormones in Hidradenitis Suppurativa (HS) and Other Skin Diseases

Role of Hormones in Hidradenitis Suppurativa (HS) and Other Skin Diseases

Purpose of this Study

We are doing this study to understand how sex hormones (chemicals that tell cells and body parts to do certain things), such as estrogens and androgens, impact skin diseases like hidradenitis suppurativa (HS). To better understand this, we are enrolling both people who have diagnosed skin diseases and healthy volunteers who have no skin issues.

Who Can Participate?

Eligibility

Adults 18 years of age or older who:

<strong>If you are a candidate with skin disease</strong><ul>
<li>Are diagnosed with HS or any other skin condition that is currently active</li>
<li>Can independently complete surveys about your symptoms</li></ul>
<strong>If you are a healthy candidate</strong><ul>
<li>Are diagnosed with HS or any other skin condition that is currently active</li>
<li>Can independently complete surveys about your symptoms</li>
<li>Are willing to have skin biopsies</li></ul>
For more information about who can join this study, please contact the study team at <a href="mailto: connor.whatley@duke.edu"> connor.whatley@duke.edu.</a>

Age Range

18-110
Looking for Healthy Participants
Yes

What is Involved?

If you choose to join this study, we will record demographic information such as your age, sex, race/ethnicity, and email address. We will also review your medical chart to find information that will be helpful in understanding your skin's health and condition.

At each visit, we will ask you to complete questionnaires in addition to collecting labs that include:
<li>Blood draws</li>
<li>Skin biopsies of normal and affected skin</li>
<li>Skin swabs</li>
<li>Skin tape stripping</li></ul>

Locations

Duke University Hospital

Visit Timing

Weekdays

Compensation

Yes

Spanish Materials Available

No

Study Details

Full Title

Role of hormones in hidradenitis suppurativa and other skin diseases

Principal Investigator

Tarannum
Jaleel

Protocol Number

PRO00105932

Phase

N/A

Enrollment Status

Open to Enrollment